Items where Author is "Sedaghat, N."

(2022) Atherosclerosis and multiple sclerosis: An overview on the prevalence of risk factors. MULTIPLE SCLEROSIS AND RELATED DISORDERS. ISSN 2211-0348 2211-0356 J9 - MULT SCLER RELAT DIS

(2022) Detection of anti-NMDA receptor antibodies following BBIBP-CorV COVID-19 vaccination in a rituximab-treated person with multiple sclerosis presenting with manifestations of an acute relapse. HUMAN VACCINES & IMMUNOTHERAPEUTICS. ISSN 2164-5515 2164-554X J9 - HUM VACC IMMUNOTHER

(2022) Does COVID-19 increase the long-term relapsing-remitting multiple sclerosis clinical activity? A cohort study. BMC NEUROLOGY. ISSN 1471-2377 J9 - BMC NEUROL

(2022) Inducing chimeric antigen receptor (CAR) regulatory T cells in-vivo: A novel concept for a potential feasible cure of demyelinating diseases. MULTIPLE SCLEROSIS AND RELATED DISORDERS. ISSN 2211-0348 2211-0356 J9 - MULT SCLER RELAT DIS

(2022) Multiple sclerosis disease-modifying therapies and COVID-19 vaccines: a practical review and meta-analysis. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. pp. 986-994. ISSN 0022-3050 1468-330X J9 - J NEUROL NEUROSUR PS

(2022) Re-Evaluating the Effect of Preoperative Tranexamic Acid on Blood Loss and Field Quality During Rhinoplasty: A Randomized Double-Blinded Controlled Trial. Aesthetic Plast Surg. pp. 1314-1320. ISSN 0364-216x

(2022) Risk factors of severe COVID-19 in people with multiple sclerosis : A systematic review and meta. REVUE NEUROLOGIQUE. pp. 121-128. ISSN 0035-3787 2213-0004 J9 - REV NEUROL-FRANCE

(2022) SARS-CoV-2 serology among people with multiple sclerosis on disease-modifying therapies after BBIBP-CorV (Sinopharm) inactivated virus vaccination: Same story, different vaccine. MULTIPLE SCLEROSIS AND RELATED DISORDERS. ISSN 2211-0348 2211-0356 J9 - MULT SCLER RELAT DIS

(2022) Self-Reported safety of the BBIBP-CorV (Sinopharm) COVID-19 vaccine among Iranian people with multiple sclerosis. HUMAN VACCINES & IMMUNOTHERAPEUTICS. ISSN 2164-5515 2164-554X J9 - HUM VACC IMMUNOTHER

(2021) Acute relapse and poor immunization following COVID-19 vaccination in a rituximab-treated multiple sclerosis patient. Hum Vaccin Immunother. pp. 1-3. ISSN 2164-5515

(2021) COVID-19 and the Risk of Relapse in Multiple Sclerosis Patients: A Fight with No Bystander Effect? Multiple Sclerosis and Related Disorders. ISSN 2211-0348

(2021) Conus medullaris involvement in demyelinating disorders of the CNS: A comparative study. Mult Scler Relat Disord. p. 103127. ISSN 2211-0348

(2021) Movement Disorders Associated with COVID-19. PARKINSONS DISEASE. ISSN 2090-8083 2042-0080 J9 - PARKINSONS DIS-US

(2021) Myasthenia gravis and coronavirus disease 2019: A report from Iran. CURRENT JOURNAL OF NEUROLOGY. pp. 162-165. ISSN 2717-011X J9 - CURR J NEUROL

(2021) Outcome of COVID-19 infection in multiple sclerosis patients receiving disease-modifying therapies. JOURNAL OF RESEARCH IN MEDICAL SCIENCES. ISSN 1735-1995 1735-7136 J9 - J RES MED SCI

(2016) Evaluation of lymphocyte activation gene3 (LAG-3) on regulatory T cells in patients with multiple sclerosis by intervention effect of fingolimod. Journal of Isfahan Medical School. pp. 701-706. ISSN 10277595 (ISSN)

(2016) IL-27 plasma level in relapsing remitting multiple sclerosis subjects: The double-faced cytokine. Journal of immunoassay & immunochemistry. pp. 659-70. ISSN 1532-4230 (Electronic) 1532-1819 (Linking)

(2015) Effect of Fingolimod on Platelet Count Among Multiple Sclerosis Patients. International Journal of Preventive Medicine. ISSN 2008-7802

(2015) IL-23 Plasma level measurement in relapsing remitting multiple sclerosis (RRMS) patients compared to healthy subjects. Immunological Investigations. pp. 36-44. ISSN 0882-0139